Dallas Flies, Ph.D.
Affiliations: | 2010 | Johns Hopkins University, Baltimore, MD |
Area:
ImmunologyGoogle:
"Dallas Flies"Parents
Sign in to add mentorLieping Chen | grad student | 2010 | Johns Hopkins | |
(Identification and characterization of regulator of T lymphocyte activation (RTLA), a novel co-signaling molecule.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Prajapati K, Yan C, Yang Q, et al. (2024) The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies. Science Advances. 10: eadj4698 |
Wang Q, He J, Flies DB, et al. (2023) Author Correction: Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability. Scientific Reports. 13: 11603 |
Vijver SV, Singh A, Mommers-Elshof ETAM, et al. (2021) Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1. Frontiers in Immunology. 12: 733561 |
Ramos MIP, Tian L, de Ruiter EJ, et al. (2021) Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. Elife. 10 |
Han X, Vesely MD, Yang W, et al. (2019) PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Science Translational Medicine. 11 |
Wang J, Sun J, Liu LN, et al. (2019) Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nature Medicine |
Wang Q, He J, Flies DB, et al. (2017) Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability. Scientific Reports. 7: 6086 |
Flies DB, Higuchi T, Harris JC, et al. (2016) Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer. Oncoimmunology. 5: e1185583 |
Higuchi T, Flies DB, Marjon NA, et al. (2015) CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer. Cancer Immunology Research. 3: 1257-68 |
Flies DB, Higuchi T, Chen L. (2015) Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens. Journal of Immunology (Baltimore, Md. : 1950). 194: 5294-304 |